Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Birgit Luber, Joelle Deplazes, Gisela Keller, Axel Walch, Sandra Rauser, Martin Eichmann, Rupert Langer, Heinz Hoefler, Susanna Hegewisch-Becker, Gunnar Folprecht, Ewald Woell, Thomas Decker, Esther Endlicher, Sylvie Lorenzen, Falko Fend, Christian Peschel, Florian Lordick

Research output: Contribution to journal › Article › peer-review

61 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology